Beckwith-Wiedemann-Syndrom
Begutachtet von Dr Adrian Bonsall, MBBSZuletzt aktualisiert von Dr Colin Tidy, MRCGPZuletzt aktualisiert 11 Nov 2014
Erfüllt die redaktionelle Richtlinien
- HerunterladenHerunterladen
- Teilen
- Language
- Diskussion
- Ask Patient
- Audio-Version
- Zu bevorzugten Quellen bei Google hinzufügen
Hinweis zum Inhalt
Diese Seite wurde in letzter Zeit nicht überprüft. Daher haben sich möglicherweise einige Informationen oder externe Links geändert.
Medizinische Fachkräfte
Fachartikel sind für die Nutzung durch Gesundheitsfachkräfte konzipiert. Sie werden von britischen Ärzten verfasst und basieren auf Forschungsergebnissen, britischen und europäischen Richtlinien. Möglicherweise finden Sie einen unserer Gesundheitsartikel nützlicher.
Definition
Beckwith-Wiedemann syndrome (BWS) is a disorder of growth regulation exhibiting somatic overgrowth and a predisposition to embryonal tumours.1Merkmale umfassen:
Macroglossia
Abdominal wall defects
Visceromegaly
It was first described in 1964 by Dr H R Wiedemann, a geneticist from Kiel in Germany. Dr J Bruce Beckwith, a paediatric pathologist working in California, also described it in 1969. The severity of effect on the child is highly variable, with the majority minimally affected.
Pathogenese
The underlying cause is unclear. 80% of cases have genotypic abnormalities on the distal portion of chromosome 11p. The reported pattern of inheritance is autosomal dominance with variable expression. There is contiguous gene duplication at band 11p.15.5.2 This is always derived from the patient's father, whereas translocation and inversion are invariably derived from the mother. There appears to be aberrant genomic imprinting resulting from a defective or absent copy of the maternally derived gene - uniparental disomy.
Most sporadic cases lack apparent cytogenetic abnormalities. Only 2% carry inversions, translocations or deletions. 20% of sporadic cases have uniparental disomy.3 50% have loss of methylation.
Most patients with BWS show biallelic expression of insulin-like growth factor 2 (IGF2) in various tissues - see under 'Presentation', below.
Epidemiologie
Inzidenz
The incidence is estimated to be 1 in 13,700. Subfertility and assisted reproduction are associated with an increased frequency of BWS.1
Recent work has suggested an association between genetic imprinting disorders (such as BWS and Angelman's syndrome) and children conceived with assisted reproduction techniques (ARTs) such as in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI).45
Präsentation
Increasingly commonly diagnosed at prenatal ultrasound.6 Suspicious features include:
Increased abdominal circumference.
Large kidneys.
Large placenta, raised amniotic fluid volume.
Protruding tongue.
Large-for-gestational-age fetus.
Raised alpha-fetoprotein with omphalocele.
Symptome
Hypoglykämie.
Poor feeding.
Lethargie.
Problems with breathing, eating and speech, relating to the severity of macroglossia.
Anzeichen
Wachstum
Large for gestational age; the overgrowth in BWS is often the result of increased IGF2 action in the tissues. Birth weight and length are increased. Hemihypertrophy can be seen, where one part of the body, or usually all or part of one side of the body, is enlarged. This often becomes apparent in later childhood.
Accelerated growth (on 90th centile or above).
Abdominal wall defects:
Omphalocele and umbilical hernia.7
Diastasis recti causing a 'pot-belly' appearance.
Visceromegaly:
Enlarged liver, kidneys, pancreas and spleen are found.
Facial abnormalities:
Large, prominent eyes.
Creases in earlobes and pit behind the upper ear.
Pinna abnormalities, low-set ears.
Raised fontanelle, prominent occiput.
Metopic ridge, prominent on forehead due to early closure of fontanelle.
Others:
Anfälle.
Cryptorchidism.
Early bone maturation.
Naevus flammeus - stork bite mark over eyelids and forehead.
Renal structural anomalies, nephrocalcinosis.
Differentialdiagnose
Fetal overgrowth syndromes - eg, Simpson-Golabi-Behmel syndrome, Perlman syndrome, Costello syndrome.
Hyperinsulinaemia.
Hyperpituitarism.
Nesidioblastosis.
Untersuchungen
X-ray long bones.
Blood sugar testing.
X-ray, ultrasound, CT/MRI scan of abdomen.
Chromosome analysis.
Assoziierte Erkrankungen
There is an increased risk of tumour development in children with BWS:
The incidence of malignant tumours in reported cases is 5-10%.
The most common of these is Wilms' nephroblastoma. This occurs in 5-7%. Others are hepatoblastoma and adrenal tumours. Neuroblastome are less common.
The risk of cancer is age-dependent with most occurring by age 4 years. 95% have occurred by the age of 8 years.
Behandlung
Allgemeine Maßnahmen
Screening for tumours:1
The child should have alpha-fetoprotein levels (marker for hepatoblastoma) monitored until 4 years old.
Repeated abdominal ultrasound scans until 8 years old.
Hypoglycaemia:
Screening for hypoglycaemia should be undertaken in the first few days of life.1
Hypoglycaemia should be rigorously avoided and treated, when necessary.
Diazoxide can be used to inhibit insulin secretion.
Chirurgisch
If the tongue protrudes and interferes with speech and dental development, the child should be considered for reduction surgery before 4 years old.
Abdominal wall defects will need early neonatal repair. Testes may need bringing down within the scrotum.
Komplikationen
Most can be anticipated and managed:
Predisposition to embryonal malignancies:1
Most of the tumours associated with BWS occur in the first 8-10 years of life.
The most common tumours are Wilms' tumour and hepatoblastoma. Other embryonal tumours include rhabdomyosarcoma, adrenocortical carcinoma and neuroblastoma.
The overall risk for tumour development in children with BWS has been estimated at 7.5% with a range of risk estimates between 4% and 21%.
Clinical indicators of higher risks of tumour development include hemihyperplasia, nephromegaly, and nephrogenic rests.
Frühgeburt.
Monozygotic twinning (usually female and discordant).
Neonatal hypoglycaemia; uncontrolled hypoglycaemia in infancy is thought to be the major aetiological factor in the reported low IQ in BWS, rather than congenital malformation.
Prognose
The prognosis is very variable but the severe end of the spectrum may involve intrauterine, neonatal or childhood death. Death may be due to complications arising from hypoglycaemia, prematurity, cardiomyopathy, macroglossia or tumours. In contract, mildly affected children often have only subtle problems, which do not affect their quality of life.1
Exklusive Updates für medizinisches Fachpersonal
Bleiben Sie informiert mit den neuesten klinischen Updates, professionellen Einblicken und evidenzbasierten Leitlinien. Der Patient Pro-Newsletter stellt wesentliche Inhalte für Gesundheitsfachkräfte zusammen – direkt in Ihren Posteingang geliefert.
Durch das Abonnieren akzeptieren Sie unsere Datenschutzrichtlinie. Sie können sich jederzeit abmelden. Wir verkaufen Ihre Daten niemals.
Weiterführende Lektüre und Referenzen
- Weksberg R, Shuman C, Beckwith JB; Beckwith-Wiedemann syndrome. Eur J Hum Genet. 2010 Jan;18(1):8-14. doi: 10.1038/ejhg.2009.106. Epub .
- Beckwith-Wiedemann Syndrome, BWS; Online-Mendelsche-Erbfolge beim Menschen (OMIM)
- Bestor TH; Imprinting errors and developmental asymmetry. Philos Trans R Soc Lond B Biol Sci. 2003 Aug 29;358(1436):1411-5.
- Gosden R, Trasler J, Lucifero D, et al; Rare congenital disorders, imprinted genes, and assisted reproductive technology. Lancet. 2003 Jun 7;361(9373):1975-7.
- Klemetti R, Gissler M, Sevon T, et al; Children born after assisted fertilization have an increased rate of major congenital anomalies. Fertil Steril. 2005 Nov;84(5):1300-7.
- Williams DH, Gauthier DW, Maizels M; Prenatal diagnosis of Beckwith-Wiedemann syndrome. Prenat Diagn. 2005 Oct;25(10):879-84.
- Grati FR, Turolla L, D'Ajello P, et al; Chromosome 11 segmental paternal isodisomy in amniocytes from two fetuses with omphalocoele: new highlights on phenotype-genotype correlations in Beckwith-Wiedemann syndrome. J Med Genet. 2007 Apr;44(4):257-63. Epub 2007 Jan 26.
Über den RezensentenVollständige Biografie anzeigen

Dr Adrian Bonsall, MBBS
Medizinischer Autor
MA (Chemie), MBBS (Hons), DCH
Seit 2000 ist Adrian in der Notfall- und Intensivmedizin für Kinder in Sydney tätig, mit besonderen Interessen in den Bereichen Toxikologie, Trauma und Wiederbelebung.
Artikelverlauf
Artikel auch verfügbar in Englisch, Deutsch, Spanisch, Französisch, Italienisch, Portugiesisch, Hindi, Hebräisch, Arabisch, und Schwedisch.
11 Nov 2014 | Neueste Version
Mehr zu angeborenen und erblichen Störungen
- Akatalasämie
- Albinismus
- Autosomal rezessive polyzystische Nierenerkrankung
- Becker-Muskeldystrophie
- Beta-Hexosaminidase-Mangel
- Blutungsstörungen
- Brutons Agammaglobulinämie
- Chediak-Higashi-Syndrom
- Zystische Fibrose
- Edwards-Syndrom
- Ehlers-Danlos-Syndrome
- Faktor-V-Leiden-Mutation, die Thrombophilie verursacht
- Fragiles-X-Syndrom
- Hypermobilitätssyndrom
- Myopathien
- Niemann-Pick disease
- Osteochondrodysplasien
- Pompesche Glykogenspeicherkrankheit
- Tay-Sachs-Krankheit
- Wiskott-Aldrich-Syndrom


